A carregar...
A comparative study of two PODXL antibodies in 840 colorectal cancer patients
BACKGROUND: Podocalyxin (PODXL) is a transmembrane sialomucin, whose aberrant expression and/or allelic variation associates with poor prognosis and unfavourable clinicopathological characteristics in different cancers. Membranous expression of PODXL has been suggested to be an independent marker of...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4107962/ https://ncbi.nlm.nih.gov/pubmed/25004935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-494 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|